Looks like CYP is doing a bit of work at 40 odd level. Given what this company has in terms of being able to provide a solution to inevitable large demand for stem cell products in the coming years seems to have been missed by not only the market but the larger players in the stem cell game (i.e. MSB etc). You'd think that anyone who is bullish on stemcells and stem cell companies would have to be bullish on these guys?! Put some of these in the top drawer and I reckon you'd be pleasantly surprised in the coming year/years. DYOR.
Buying opportunity, page-38
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CYP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
22.0¢ |
Change
-0.025(10.2%) |
Mkt cap ! $42.42M | |||
| Open | High | Low | Value | Volume |
| 24.0¢ | 24.0¢ | 21.0¢ | $60.99K | 270.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 105502 | 20.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 21.5¢ | 7263 | 1 |
View Market Depth
| Last trade - 15.57pm 05/08/2024 (20 minute delay) ? |
| CYP (ASX) Chart |